Thermodynamic and mechanistic insights into translesion DNA synthesis catalyzed by Y-family DNA polymerase across a bulky double-base lesion of an antitumor platinum drug.
To determine how the Y-family translesion DNA polymerase η (Polη) processes lesions remains fundamental to understanding the molecular origins of the mutagenic translesion bypass. We utilized model systems employing a DNA double-base lesion derived from 1,2-GG intrastrand cross-links of a new antitumor Pt(II) complex containing a bulky carrier ligand, namely [PtCl(2)(cis-1,4-dach)] (DACH=diaminocyclohexane). The catalytic efficiency of Polη for the insertion of correct dCTP, with respect to the other incorrect nucleotides, opposite the 1,2-GG cross-link was markedly reduced by the DACH carrier ligand. This reduced efficiency of Polη to incorporate the correct dCTP could be due to a more extensive DNA unstacking and deformation of the minor groove induced in the DNA by the cross-link of bulky [PtCl(2)(cis-1,4-dach)]. The major products of the bypass of this double-base lesion produced by [PtCl(2)(cis-1,4-dach)] by Polη resulted from misincorporation of dATP opposite the platinated G residues. The results of the present work support the thesis that this misincorporation could be due to sterical effects of the bulkier 1,4-DACH ligand hindering the formation of the Polη-DNA-incoming nucleotide complex. Calorimetric analysis suggested that thermodynamic factors may contribute to the forces that governed enhanced incorporation of the incorrect dATP by Polη as well.
Department of Molecular Biophysics and Pharmacology, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Kralovopolska 135, 61265 Brno, Czech Republic.
Viktor
V
Brabec
Jaroslav
J
Malina
Nicola
N
Margiotta
Giovanni
G
Natile
Jana
J
Kasparkova
D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D002151:Calorimetry; D002384:Catalysis; D002945:Cisplatin / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis / Q000138:chemical synthesis* / Q000737:chemistry / Q000235:genetics; D004249:DNA Damage; D004259:DNA-Directed DNA Polymerase / Q000145:classification / Q000378:metabolism*; D006801:Humans; D015394:Molecular Structure; D009944:Organoplatinum Compounds / Q000737:chemistry / Q000494:pharmacology*; D013816:Thermodynamics; D000099270:Y-Family DNA Polymerases
D000970:Antineoplastic Agents; D002945:Cisplatin; D004247:DNA; D004259:DNA-Directed DNA Polymerase; D009944:Organoplatinum Compounds; C112338:Rad30 protein; D000099270:Y-Family DNA Polymerases